I. Keydar

发表

Functional Analysis of Csk and CHK Kinases in Breast Cancer Cells*

S. Jiang, H. Avraham, C. Bougeret, 2001, The Journal of Biological Chemistry.

MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERα) in regulation of the MUC1 gene expression

I. Barnea, Y. Aylon, D. Wreschner, 2006, Molecular Cancer.

Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins.

S. Spiegelman, T. Ohno, R. Sweet, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of a protein, released by the T47D cell line, immunologically related to the major envelope protein of mouse mammary tumor virus.

A. Hizi, I. Keydar, N. Segev, 1985, Proceedings of the National Academy of Sciences of the United States of America.

A Unique Mucin Immunoenhancing Peptide with Antitumor Properties

T. Fu, D. Wreschner, J. Grosso, 2004, Cancer Research.

Association of Csk-homologous Kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in Breast Cancer Cells*

M. Sliwkowski, J. Groopman, H. Avraham, 1997, Journal of Biological Chemistry.

The Chemokine CCL5 as a Potential Prognostic Factor Predicting Disease Progression in Stage II Breast Cancer Patients

A. Ben-Baruch, I. Barnea, E. Shabtai, 2006, Clinical Cancer Research.

Vaccination against breast cancer--studies in an animal model.

R. Yarden, N. Smorodinsky, D. Wreschner, 1994, Advances in experimental medicine and biology.

Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.

A. Ben-Baruch, S. Chaitchik, S. Engelberg, 1999, Cancer research.

Alteration of Met protooncogene product expression and prognosis in breast carcinomas.

I. Bièche, W. Alvord, G. V. Vande Woude, 1999, Analytical and quantitative cytology and histology.

Human epithelial tumor antigen cDNA sequences

R. Lathe, I. Tsarfaty, J. Horev, 1990 .

MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer

N. Smorodinsky, O. Sagi-Assif, M. Weiss, 1999, International journal of cancer.

Humanization of an antibody recognizing a breast cancer specific epitope by CDR-grafting.

M. Reitz, R. Gallo, B. Watkins, 1997, Immunotechnology : an international journal of immunological engineering.

Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue.

O. Elroy-Stein, D. Wreschner, H. L. Vos, 1994, European journal of biochemistry.

The production of human monoclonal anti-MMTV antibodies by in vitro immunization with anti-idiotypic antibodies.

Y. Shoenfeld, S. Chaitchik, I. Keydar, 1991, Immunology letters.

Human breast carcinoma antigen is immunologically related to the polypeptide of the group-specific glycoprotein of mouse mammary tumor virus.

S. Spiegelman, T. Ohno, R. Mesa-Tejada, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor‐potentiating function

N. Smorodinsky, M. Weiss, D. Wreschner, 1997, International journal of cancer.

Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene

M. Weiss, D. Wreschner, A. Baruch, 1996, International journal of cancer.

Dna methylation status of the MUC1 gene coding for a breast‐cancer‐associated protein

M. Weiss, D. Wreschner, I. Keydar, 1995, International journal of cancer.

Expression of a gene coding for breast tumor-associated antigen in thyroid papillary carcinoma.

N. Smorodinsky, M. Weiss, D. Wreschner, 1991, Cancer letters.

Vaccinia recombinants expressing secreted and transmembrane forms of breast cancer-associated epithelial tumour antigen (ETA).

R. Lathe, P. Chambon, M. Kieny, 1991, Vaccine.

Molecular Analysis of H23 Epithelial Tumor Antigen - Differentially Spliced Full Length cDNAs and Gene

R. Lathe, C. Hart, I. Tsarfaty, 1991 .

A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen. cDNA cloning, expression of the transfected gene and over-expression in breast cancer tissue.

R. Lathe, I. Tsarfaty, J. Horev, 1990, European journal of biochemistry.

H23 Monoclonal Antibody Recognizes a Breast Tumor Associated Antigen: Clinical and Molecular Studies

I. Tsarfaty, J. Horev, A. Hizi, 1989 .

Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens.

I. Tsarfaty, A. Hizi, S. Chaitchik, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Breast cancer : progress in biology, clinical management, and prevention : proceedings of the International Association for Breast Cancer Reseach Conference, Tel-Aviv, Israel, March 1989

I. Keydar, J. Hager, M. Rich, 1989 .

Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease.

A. Ben-Baruch, S. Chaitchik, G. Luboshits, 2002, The Israel Medical Association journal : IMAJ.

Multiple protein forms of the human breast tumor-associated epithelial membrane antigen (EMA) are generated by alternative splicing and induced by hormonal stimulation.

I. Tsarfaty, D. Wreschner, A. Dion, 1990, Biochemical and biophysical research communications.

Detection in human breast carcinomas of an antigen immunologically related to a group-specific antigen of mouse mammary tumor virus.

S. Spiegelman, T. Ohno, R. Mesa-Tejada, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer‐associated antigens by anti‐idiotypic antibodies

Y. Shoenfeld, N. Smorodinsky, I. Keydar, 1988, European journal of immunology.

Isolation and characterization of an expressed hypervariable gene coding for a breast-cancer-associated antigen.

R. Lathe, I. Tsarfaty, J. Horev, 1990, Gene.

Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D).

D. Chalbos, H. Rochefort, F. Vignon, 1982, The Journal of clinical endocrinology and metabolism.

Human Endogenous Retrovirus (HERV-K) Reverse Transcriptase as a Breast Cancer Prognostic Marker 1,2,3

I. Tsarfaty, J. Resau, A. Hizi, 2008 .

Expression of genes coding for pS2, c‐erbB2, estrogen receptor and the H23 breast tumor‐associated antigen

I. Tsarfaty, M. Weiss, D. Wreschner, 1990, FEBS letters.

Detection of viral proteins in mouse mammary tumors by immunoperoxidase staining of paraffin sections.

S. Spiegelman, T. Ohno, R. Mesa-Tejada, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Rodent brain growth stages: an analytical review.

H. Epstein, I. Keydar, A. Gottlieb, 1977, Biology of the neonate.

breast carcinomas. Immunohistochemical detection of a cross-reacting virus antigen in mouse mammary tumors and human

S. Spiegelman, T. Ohno, R. Mesa-Tejada, 2011 .

Immunohistochemical detection of a cross-reacting virus antigen in mouse mammary tumors and human breast carcinomas.

S. Spiegelman, T. Ohno, R. Mesa-Tejada, 1978, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

DETECTION OF A CROSS-REACTING VIRUS ANTIGEN IN MOUSE MAMMARY TUMORS AND HUMAN BREAST CARCINOMAS'

S. Spiegelman, T. Ohno, R. Mesa-Tejada, 1978 .

Human Monoclonal Antibodies Directed Against Viral Antigens

R. Lupu, S. Argov, Y. Shoenfeld, 1988 .

Possible diagnostic implications of a mammary tumor virus related protein in human breast cancer

S. Spiegelman, T. Ohno, R. Mesa-Tejada, 1980, Cancer.

Immunohistochemical evidence for RNA virus related components in human breast cancer.

S. Spiegelman, T. Ohno, R. Mesa-Tejada, 1979, Annals of clinical and laboratory science.

Human Monoclonal Antibodies Directed Against HuMTV Antigens from Human Breast Cancer Cells

Y. Shoenfeld, I. Tsarfaty, N. Smorodinsky, 1986 .

Increased incidence of mouse mammary tumor virus‐related antigen in tunisian patients with breast cancer

P. Levine, R. Mesa-Tejada, I. Keydar, 1984, International journal of cancer.

A viral antigen as a marker for the prognosis of human breast cancer.

A. Hizi, S. Chaitchik, I. Keydar, 1982, European journal of cancer & clinical oncology.

Expression of a mouse mammary tumor virus cross-reacting antigen on the cell surface of T-47D, a human mammary cell line

A. Hizi, I. Keydar, Y. Ben‐Shaul, 1982 .

Antigen as a Marker for the Prognosis of Breast Cancer

A. Hizi, S. Chaitchik, T. Aviv, 1982 .

Establishment and characterization of a cell line of human breast carcinoma origin.

M. Radu, I. Keydar, F. Weiss, 1979, European journal of cancer.

A Novel Protein Derived from the MUC1 Gene by Alternative Splicing and Frameshifting*

N. Smorodinsky, F. Levitin, M. Weiss, 2005, Journal of Biological Chemistry.

The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein.

N. Smorodinsky, D. Wreschner, A Baruch, 1999, Cancer research.

RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion

L. Shaw, J. Settleman, H. Avraham, 2000, Oncogene.

The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors.

T. Meshel, A. Ben-Baruch, I. Keydar, 2005, Cancer letters.

Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.

T. Meshel, A. Ben-Baruch, M. Ehrlich, 2008, Cytokine.

The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.

M. Weil, D. Shahbazian, A. Ben-Baruch, 2002, Cancer research.

The met proto-oncogene receptor and lumen formation.

G. V. Vande Woude, I. Tsarfaty, J. Resau, 1992, Science.

Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

I. Tsarfaty, J. Resau, A. Hizi, 2008, Neoplasia.

Generation of ligand‐receptor alliances by “SEA” module‐mediated cleavage of membrane‐associated mucin proteins

S. Gordon, N. Smorodinsky, M. McGuckin, 2002, Protein science : a publication of the Protein Society.

Recognition of peptidyl epitopes by polymorphic epithelial mucin (PEM)-specific monoclonal antibodies.

N. Smorodinsky, D. Wreschner, P. Major, 1991, Hybridoma.

Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins Cytokine receptor‐like molecules

O. Elroy-Stein, D. Wreschner, A. Baruch, 1994, FEBS letters.

Isolation and characterization of full length cDNA coding for the H23 breast tumor associated antigen

R. Lathe, I. Tsarfaty, J. Horev, 1989 .

Csk Homologous Kinase, a Novel Signaling Molecule, Directly Associates with the Activated ErbB-2 Receptor in Breast Cancer Cells and Inhibits Their Proliferation*

Y. Yarden, H. Avraham, I. Keydar, 1998, The Journal of Biological Chemistry.

Antibody internalization studied using a novel IgG binding toxin fusion.

I. Barnea, I. Benhar, I. Keydar, 2007, Journal of immunological methods.

Does a novel form of the breast cancer marker protein, MUC1, act as a receptor molecule that modulates signal transduction?

N. Smorodinsky, D. Wreschner, A. Baruch, 1994, Advances in experimental medicine and biology.

Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity.

I. Benhar, I. Keydar, Y. Mazor, 2005, Molecular immunology.

Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodies.

N. Smorodinsky, M. Weiss, D. Wreschner, 1996, Biochemical and biophysical research communications.

Analysis of the promoter of the MUC1 gene overexpressed in breast cancer

L. Mittelman, R. Sarid, D. Wreschner, 1999, FEBS letters.